Adma stock forecast following earnings call

Following earnings call, ADMA stock forecast improved as management revised full-year revenue guidance upward by $5M, indicating stronger commercial execution. Compared to the Zacks Consensus Estimate of $112.2 million, the reported revenues represent a surprise of +4.77%. The EPS surprise was -6.67%. Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report Short interest in ADMA stock dropped 10% in the latest reporting period, reinforcing bullish ADMA stock forecast sentiment among momentum-focused traders.